The country’s top infectious disease expert expects the COVID-19 vaccine to be available to children ages 5 to 11 in early November; Walmart recalls aromatherapy spray due to contamination with rare and deadly bacteria; COVID-19-related brain fog has been found to persist in patients for months after infection.
COVID-19 vaccines likely to be available to children in November
As reported by Reuters, children ages 5 to 11 will likely be able to be vaccinated against COVID-19 from early November. President Joe Biden’s chief medical adviser, Anthony Fauci, MD, said yesterday that he predicts the CDC’s regulatory approval and recommendation to be issued in the first or second week of November. Currently, FDA officials are reviewing Pfizer/BioNTech’s application of its 2-dose vaccine in younger children, with a panel of outside advisors set to meet on Oct. 26. The CDC will meet on November 2 and 3 to discuss their recommendations.
Aromatherapy spray recalled due to contamination with deadly bacteria
About 3,900 bottles of essential oil aromatherapy spray from Walmart are being recalled due to possible contamination with a rare and deadly bacteria, Burkholderia pseudomallei. Reported by NPR, Walmart’s Better Homes & Gardens brand essential oil infused aromatherapy room spray with gemstones has been linked with 4 confirmed cases, with 2 cases being fatal. The bacterium is known to cause meliodosis, a difficult-to-diagnose and deadly condition that usually develops in tropical climates, particularly Southeast Asia and Northern Australia.
JAMA study shows COVID-19-related brain fog can last for months
Reported by CNN, according to JAMA Network, open cognitive impairment from COVID-19, also known as brain fog, was found in a recent study that persists for months after infection, even in people with no cases of serious illness or hospitalization. In the study, the findings indicated that nearly 1 in 4 patients with COVID-19 from the Mount Sinai Health System registry experienced a cognitively related problem, with hospitalized individuals more likely to experience brain fog after infection. Overall, 23% of patients reported problems with memory recall, 18% had a deficit in cognitive processing speed, and 15% had a deficit in phonemic fluency in their speech.